title: Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats.
abstract: Dimethyloxalylglycine (DMOG) is an inhibitor of prolyl-4-hydroxylase domain (PHD) enzymes that regulate the stability of hypoxia-inducible factor (HIF). We investigated the effect of DMOG on the outcome after permanent and transient middle cerebral artery occlusion (p/tMCAO) in the rat. Before and after pMCAO, rats were treated with 40 mg/kg, 200 mg/kg DMOG, or vehicle, and with 40 mg/kg or vehicle after tMCAO. Serial magnetic resonance imaging (MRI) was performed to assess infarct evolution and regional cerebral blood flow (rCBF). Both doses significantly reduced infarct volumes, but only 40 mg/kg improved the behavior after 24 hours of pMCAO. Animals receiving 40 mg/kg were more likely to maintain rCBF values above 30% from the contralateral hemisphere within 24 hours of pMCAO. DMOG after tMCAO significantly reduced the infarct volumes and improved behavior at 24 hours and 8 days and also improved the rCBF after 24 hours. A consistent and significant upregulation of both mRNA and protein levels of vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) was associated with the observed neuroprotection, although this was not consistently related to HIF-1α levels at 24 hours and 8 days. Thus, DMOG afforded neuroprotection both at 24 hours after pMCAO and at 24 hours and 8 days after tMCAO. This effect was associated with an increase of VEGF and eNOS and was mediated by improved rCBF after DMOG treatment.
authors.affiliation: Nuffield Department of Clinical Medicine, Acute Stroke Programme, University of Oxford, Oxford, UK. simon.nagel@med.uni-heidelberg.de
authors.forename: Simon
authors.initials: S
authors.lastname: Nagel
authors.forename: Michalis
authors.initials: M
authors.lastname: Papadakis
authors.forename: Ruoli
authors.initials: R
authors.lastname: Chen
authors.forename: Lisa C
authors.initials: LC
authors.lastname: Hoyte
authors.forename: Keith J
authors.initials: KJ
authors.lastname: Brooks
authors.forename: Daniel
authors.initials: D
authors.lastname: Gallichan
authors.forename: Nicola R
authors.initials: NR
authors.lastname: Sibson
authors.forename: Chris
authors.initials: C
authors.lastname: Pugh
authors.forename: Alastair M
authors.initials: AM
authors.lastname: Buchan
mesh_terms: D000600:Amino Acids, Dicarboxylic / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001784:Blood Gas Analysis; D015153:Blotting, Western; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology; D002545:Brain Ischemia / Q000188:drug therapy* / Q000473:pathology / Q000523:psychology; D002908:Chronic Disease; D015870:Gene Expression / Q000187:drug effects; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D020244:Infarction, Middle Cerebral Artery / Q000473:pathology; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000473:pathology / Q000523:psychology; D008279:Magnetic Resonance Imaging; D008297:Male; D018696:Neuroprotective Agents; D052250:Nitric Oxide Synthase Type III / Q000096:biosynthesis / Q000235:genetics; D012313:RNA / Q000235:genetics; D051381:Rats; D017208:Rats, Wistar; D020133:Reverse Transcriptase Polymerase Chain Reaction; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis / Q000235:genetics
chemical_list: D000600:Amino Acids, Dicarboxylic; C497444:Hif1a protein, rat; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D018696:Neuroprotective Agents; D042461:Vascular Endothelial Growth Factor A; D012313:RNA; D052250:Nitric Oxide Synthase Type III; C040947:oxalylglycine
references.citation: Trends Neurosci. 2004 May;27(5):283-9
references.pmid: 15111011
references.citation: Stroke. 1989 Aug;20(8):1037-43
references.pmid: 2756535
references.citation: Magn Reson Imaging. 1994;12(3):455-60
references.pmid: 8007775
references.citation: Neurol Res. 2006 Jan;28(1):38-45
references.pmid: 16464361
references.citation: Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H542-8
references.pmid: 15805230
references.citation: J Neurosci Res. 2005 Jan 1-15;79(1-2):180-4
references.pmid: 15573409
references.citation: Science. 2001 Nov 9;294(5545):1337-40
references.pmid: 11598268
references.citation: Stroke. 1996 Aug;27(8):1381-5
references.pmid: 8711806
references.citation: J Physiol. 2004 Oct 1;560(Pt 1):21-6
references.pmid: 15319416
references.citation: J Cereb Blood Flow Metab. 1999 May;19(5):467-82
references.pmid: 10326714
references.citation: Stroke. 2009 Dec;40(12):e647-56
references.pmid: 19834012
references.citation: Stroke. 1995 Apr;26(4):636-42; discussion 643
references.pmid: 7709411
references.citation: Vascul Pharmacol. 2009 Aug-Sep;51(2-3):110-8
references.pmid: 19524066
references.citation: Curr Pharm Des. 2004;10(8):821-33
references.pmid: 15032687
references.citation: Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10212-7
references.pmid: 16009933
references.citation: Neuroradiology. 2007 Feb;49(2):93-102
references.pmid: 17177065
references.citation: Antioxid Redox Signal. 2010 Apr;12(4):481-501
references.pmid: 19754349
references.citation: Nature. 2001 Aug 9;412(6847):641-7
references.pmid: 11493922
references.citation: Brain Res Rev. 2008 Nov;59(1):22-33
references.pmid: 18514916
references.citation: Magn Reson Med. 1995 Sep;34(3):293-301
references.pmid: 7500865
references.citation: J Biol Chem. 2005 Dec 16;280(50):41732-43
references.pmid: 16227210
references.citation: Gastroenterology. 2010 Mar;138(3):1143-54.e1-2
references.pmid: 19818783
references.citation: Neurobiol Dis. 2008 Sep;31(3):433-41
references.pmid: 18602008
references.citation: J Neurosci Res. 2007 Mar;85(4):740-7
references.pmid: 17243175
references.citation: Neurobiol Dis. 2007 Apr;26(1):243-52
references.pmid: 17306552
references.citation: Biochem J. 2007 Jul 1;405(1):1-9
references.pmid: 17555402
references.citation: Nat Genet. 2008 Feb;40(2):170-80
references.pmid: 18176562
references.citation: Circulation. 2007 Aug 14;116(7):774-81
references.pmid: 17646578
references.citation: Pediatr Res. 2001 May;49(5):614-7
references.pmid: 11328942
references.citation: FASEB J. 2006 Jun;20(8):1185-7
references.pmid: 16641198
references.citation: Brain Res. 1992 Mar 6;574(1-2):171-7
references.pmid: 1386274
references.citation: Brain Res Rev. 2009 Dec 11;62(1):99-108
references.pmid: 19786048
references.citation: Science. 2001 Apr 20;292(5516):468-72
references.pmid: 11292861
references.citation: J Cereb Blood Flow Metab. 2005 Feb;25(2):204-16
references.pmid: 15678123
references.citation: Gastroenterology. 2008 Jan;134(1):156-65
references.pmid: 18166353
references.citation: Nat Chem Biol. 2008 Mar;4(3):152-6
references.pmid: 18277970
references.citation: Cell Mol Life Sci. 2009 Nov;66(22):3539-54
references.pmid: 19756382
references.citation: J Neurosci. 2007 Jun 6;27(23):6320-32
references.pmid: 17554006
references.citation: Cell. 2009 Mar 6;136(5):839-851
references.pmid: 19217150